ANI To Divest Two And Agree To Other Provisions To Close Novitium Deal
Proposed Merger Anticipated To Close This Month Following FTC Settlement
Before closing its acquisition of fellow US-based manufacturer Novitium Pharma, ANI Pharmaceuticals must agree to several orders, including divestment of rights and/or assets for two generic products.
